Frontlight ResearchEarly access
TerminatedNo phase
Timing of Revascularization in Patients With Diabetic Foot Ulcer and Non-critical Peripheral Artery Disease
Key facts
- Who runs it
- Insel Gruppe AG, University Hospital Bern
- Where
- Switzerland4 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 10 people enrolled
- Started
- 25 Jan 2022
- Ended
- 18 Sept 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Revascularization
- Standard wound care
- Record updated
- 19 December 2024
- Why it stopped
- High pre-screening failure and insufficient recruited patients
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- Informed consent as documented by signature
- Patients that are at least 18 years old
- Patients that have at least one DFU(s) of ≥ 0.2 cm2 and ≤ 10 cm2 as assessed by the ruler method multiplying the greatest length and width of the ulcer after debridement to determine the surface area. The largest eligible ulcer (≤ 10 cm2) will be defined as index ulcer and the corresponding extremity as index limb (in case of multiple equally sized ulcers the following rules will apply: If on different feet, the dominant side and if on the same foot, the more peripheral one will be the index ulcer)
- Patients that have non-critical LEAD of the index leg, defined by a single non-invasive examination at screening:; Ankle brachial index (ABI) ≥ 0.5 and ≤ 0.9 AND absolute ankle pressure ≥ 50 mmHg OR; ABI > 0.9 OR incompressible ankle pressures AND toe brachial index (TBI) ≤ 0.7 AND absolute toe pressure ≥ 30 mmHg
- Patients on medical treatment for glycemic control with diagnosis of diabetes mellitus that was assessed by criteria as recommended by the guideline 2019 "ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD". Or patient without medical treatment but diagnosed with diabetes mellitus via HbA1c
- Patients with life expectancy > 12 months and without any disabilities due to end-stage cancer, heart failure, severe chronic obstructive pulmonary disease (COPD), or dementia
Who cannot take part
- Any revascularization procedure at the index leg within 3 months before randomization
- Participation in another drug study within the 30 days preceding or during the present study
- Severe infection at the index foot according to IDSA classification
- Patient refuses minor amputation despite strong recommendation due to severe infection, necrosis or osteomyelitis at screening assessment
- Non-compliance for any reason to procedures or study assessments (e.g. due to cognitive impairment or geographic distance)
- Untreated known antiphospholipid antibody syndrome and polycythaemia vera
- Known significant bleeding risk, or known coagulation disorder (INR > 3.0 and platelet count < 30,000/mm3) without any option to correct within 7 calendar days after initial wound assessment
- Critical limb ischemia of the index leg defined as ABI ≤ 0.4 (or absolute ankle pressure < 50 mmHg)
- No option to assess for toe pressure due to any reason at baseline if ABI > 0.9 or incompressible ankle pressures and patient inclusion is based on the toe pressure criteria
- Need for major amputation
- Positive urine or blood pregnancy test result, breast feeding or intention to become pregnant
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study investigates whether, compared to standard treatment, immediate restoration of blood flow (revascularization) can reduce complications and improve diabetic foot ulcer healing.
The 2 groups in the trial
- Control ArmExisting treatment, for comparison
Standard wound care for diabetic wound ulcer
Treatment: Standard wound care
- Immediate revascularizationTreatment being tested
Patient will have revascularization 0 - 7 days after initial wound assessment and then receive standard wound care for diabetic wound ulcer
Treatment: Revascularization and Standard wound care
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Timing of Revascularization in Patients With Diabetic Foot Ulcer and Non-critical Peripheral Artery Disease: a Randomized, Controlled Trial
- Record updated
- 19 December 2024